EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Epidemiology of Second Attack of Cardiovascular Events in Patients with Type 2 Diabetes

Kenji Kuroki, Fumihiro Sakakibara, Mio Sakuma, Hisao Ogawa, Hirofumi Soejima, Sadanori Okada, Izuru Masuda, Masako Waki, Hideaki Jinnouchi, Yoshihiko Saito, Takeshi Morimoto

Journal of Cardiovascular Development and Disease · 2026-11-11 · 13 (11) · 586

DOI: 10.3390/jcdd13110586 ↗
AbstractBibliografische Angaben

Abstract

The incremental risks of cardiovascular disease (CVD) after the first CVD event remain unclear because of the difficulty of assessing how risks changed from the pre-event to the post-event period. A long-term follow-up study was conducted in patients with type 2 diabetes. The endpoints were CVD, defined as ischemic stroke (IS) or coronary artery disease (CAD), and all-cause mortality. Two cohorts were defined: the pre-event and post-event cohorts. The incidence was analyzed using the Kaplan–Meier method, and adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox proportional hazards models. The post-event cohort was further stratified by the type of the first event (IS or CAD). Among 2535 participants, 317 had a first CVD event, and 293 were included in the post-event cohort. Compared with the pre-event cohort, the post-event cohort had significantly higher risks of recurrent CVD (adjusted HR 2.24, 95% CI 1.63–3.06) and all-cause mortality (adjusted HR 2.07, 95% CI 1.59–2.69). Within the post-event cohort, recurrent CVD risk showed no difference between the IS and CAD groups, but all-cause mortality was significantly higher in the IS group. Patients with type 2 diabetes who experienced a first CVD event had a twofold increased risk of recurrent CVD events and all-cause mortality.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →